Article
Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway.
The EMBO journal - 6 Sept 2006
Bousquet Corinne, Guillermet-Guibert Julie, Saint-Laurent Nathalie, Archer-Lahlou Elodie, Lopez Frédéric, Fanjul Marjorie, Ferrand Audrey, Fourmy Daniel, Pichereaux Carole, Monsarrat Bernard, Pradayrol Lucien, Estève Jean-Pierre, Susini Christiane
Abstract excerpt
Phosphatidylinositol 3-kinase (PI3K) regulates many cellular functions including growth and survival, and its excessive activation is a hallmark of cancer. Somatostatin, acting through its G protein-coupled receptor (GPCR) sst2, has potent proapoptotic and anti-invasive activities on normal and cancer cells. Here, we report a novel mechanism for inhibiting PI3K activity. Somatostatin, acting through sst2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
